MedPath
TGA Approval

LITFULO ritlecitinib (as tosylate) 50 mg hard capsule bottle (427294)

427294

LITFULO ritlecitinib (as tosylate) 50 mg hard capsule bottle

Pfizer Australia Pty Ltd

July 9, 2024

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/fcf8d948441af628245649a7f9d5ad35.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/1878adb43f3e86d120c8632f0a1ee654.pdf

Active Ingredients

ritlecitinib tosylate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LITFULO ritlecitinib (as tosylate) 50 mg hard capsule bottle (427294) - TGA 批准文号 | MedPath